Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Multicomponent Bioluminescence Imaging with a π-Extended Luciferin.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Yao Z; Zhang BS; Steinhardt RC; Mills JH; Prescher JA
- Source:
Journal of the American Chemical Society [J Am Chem Soc] 2020 Aug 19; Vol. 142 (33), pp. 14080-14089. Date of Electronic Publication: 2020 Aug 04.
- Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
- Language:
English
- Additional Information
- Source:
Publisher: American Chemical Society Country of Publication: United States NLM ID: 7503056 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5126 (Electronic) Linking ISSN: 00027863 NLM ISO Abbreviation: J Am Chem Soc Subsets: MEDLINE
- Publication Information:
Publication: Washington, DC : American Chemical Society
Original Publication: Easton, Pa. [etc.]
- Subject Terms:
- Abstract:
Bioluminescence imaging with luciferase-luciferin pairs is commonly used for monitoring biological processes in cells and whole organisms. Traditional bioluminescent probes are limited in scope, though, as they cannot be easily distinguished in biological environments, precluding efforts to visualize multicellular processes. Additionally, many luciferase-luciferin pairs emit light that is poorly tissue penetrant, hindering efforts to visualize targets in deep tissues. To address these issues, we synthesized a set of π-extended luciferins that were predicted to be red-shifted luminophores. The scaffolds were designed to be rotationally labile such that they produced light only when paired with luciferases capable of enforcing planarity. A luciferin comprising an intramolecular "lock" was identified as a viable light-emitting probe. Native luciferases were unable to efficiently process the analog, but a complementary luciferase was identified via Rosetta-guided enzyme design. The unique enzyme-substrate pair is red-shifted compared to well-known bioluminescent tools. The probe set is also orthogonal to other luciferase-luciferin probes and can be used for multicomponent imaging. Four substrate-resolved luciferases were imaged in a single session. Collectively, this work provides the first example of Rosetta-guided design in engineering bioluminescent tools and expands the scope of orthogonal imaging probes.
- References:
ACS Chem Biol. 2021 Apr 16;16(4):682-690. (PMID: 33729750)
Anal Biochem. 2007 Feb 15;361(2):253-62. (PMID: 17181991)
Angew Chem Int Ed Engl. 2014 Nov 24;53(48):13059-63. (PMID: 25266918)
J Biomed Opt. 2005 Jul-Aug;10(4):41210. (PMID: 16178634)
Chem Soc Rev. 2016 Oct 24;45(21):6048-6077. (PMID: 27711774)
J Phys Chem A. 2010 Aug 12;114(31):8075-82. (PMID: 20684579)
Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2275-85. (PMID: 18661130)
Anal Bioanal Chem. 2010 Oct;398(4):1809-17. (PMID: 20711766)
Curr Opin Chem Biol. 2011 Apr;15(2):201-10. (PMID: 21185770)
Biochemistry. 2017 Oct 3;56(39):5178-5184. (PMID: 28745860)
Protein Sci. 2006 Dec;15(12):2785-94. (PMID: 17132862)
Angew Chem Int Ed Engl. 2010 Jul 5;49(29):4915-8. (PMID: 20540127)
Nature. 2019 Jan;565(7737):106-111. (PMID: 30568301)
Biochemistry. 2018 Feb 6;57(5):663-671. (PMID: 29224332)
Photochem Photobiol. 1997 Oct;66(4):523-31. (PMID: 9337626)
ACS Chem Biol. 2018 Jul 20;13(7):1734-1740. (PMID: 29439568)
PLoS One. 2011 Apr 22;6(4):e19277. (PMID: 21544210)
Elife. 2019 Oct 15;8:. (PMID: 31610848)
Annu Rev Anal Chem (Palo Alto Calif). 2019 Jun 12;12(1):129-150. (PMID: 30786216)
Nat Commun. 2016 Aug 19;7:12405. (PMID: 27539380)
Curr Opin Chem Biol. 2018 Aug;45:148-156. (PMID: 29879594)
Angew Chem Int Ed Engl. 2016 Apr 11;55(16):4943-6. (PMID: 26991209)
J Am Chem Soc. 2014 Oct 8;136(40):14153-9. (PMID: 25211609)
J Am Chem Soc. 2017 Feb 15;139(6):2351-2358. (PMID: 28106389)
Curr Opin Chem Biol. 2010 Feb;14(1):80-9. (PMID: 19962933)
Nat Biotechnol. 2009 Jul;27(7):624-5. (PMID: 19587667)
ACS Comb Sci. 2017 Sep 11;19(9):594-599. (PMID: 28742969)
Science. 2018 Feb 23;359(6378):935-939. (PMID: 29472486)
Biochemistry. 2016 Aug 30;55(34):4764-76. (PMID: 27391007)
Photochem Photobiol. 2017 Mar;93(2):479-485. (PMID: 27861940)
J Am Chem Soc. 2009 Aug 19;131(32):11590-605. (PMID: 19722653)
Anal Chem. 2006 Mar 1;78(5):1520-7. (PMID: 16503603)
Nature. 2013 Sep 12;501(7466):212-216. (PMID: 24005320)
J Biomed Opt. 2004 May-Jun;9(3):578-86. (PMID: 15189096)
Medchemcomm. 2014 Mar 1;5(3):255-267. (PMID: 27594981)
Biochemistry. 2003 Sep 9;42(35):10429-36. (PMID: 12950169)
Science. 2015 Feb 20;347(6224):863-867. (PMID: 25700516)
Biochemistry. 2013 Jan 8;52(1):19-27. (PMID: 23205709)
ACS Cent Sci. 2019 Jun 26;5(6):949-959. (PMID: 31263754)
Chem Sci. 2017 Jun 1;8(6):4546-4557. (PMID: 28936332)
Nat Commun. 2016 Jun 14;7:11856. (PMID: 27297211)
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4551-9. (PMID: 25313043)
Nature. 2018 Sep;561(7724):485-491. (PMID: 30209393)
Acc Chem Res. 2019 Nov 19;52(11):3039-3050. (PMID: 31593431)
J Am Chem Soc. 2014 Sep 24;136(38):13277-82. (PMID: 25208457)
Chem Sci. 2015 Apr 1;6(4):2237-2251. (PMID: 29449923)
Chem Biol. 2010 Jun 25;17(6):646-57. (PMID: 20609414)
Nat Commun. 2018 Jan 9;9(1):132. (PMID: 29317625)
Acc Chem Res. 2016 Nov 15;49(11):2372-2380. (PMID: 27696815)
Phys Med Biol. 1980 Jul;25(4):695-709. (PMID: 7454759)
ACS Synth Biol. 2017 Mar 17;6(3):416-420. (PMID: 28033708)
Biochemistry. 2007 Dec 4;46(48):13847-55. (PMID: 17994766)
Chem Sci. 2016 Jul 1;7(7):4485-4491. (PMID: 30155095)
ACS Cent Sci. 2017 Dec 27;3(12):1254-1261. (PMID: 29296665)
RSC Adv. 2017 Jan 16;7(7):3975-3982. (PMID: 28496975)
Curr Opin Chem Biol. 2010 Feb;14(1):71-9. (PMID: 19879798)
Nat Med. 2003 Jan;9(1):123-8. (PMID: 12514725)
Angew Chem Int Ed Engl. 2014 Jan 13;53(3):847-50. (PMID: 24282138)
Biochemistry. 2019 Oct 22;58(42):4293-4303. (PMID: 31560532)
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12728-12732. (PMID: 30478037)
Nature. 2019 May;569(7757):509-513. (PMID: 31068699)
Assay Drug Dev Technol. 2007 Feb;5(1):127-36. (PMID: 17355205)
- Grant Information:
R01 GM107630 United States GM NIGMS NIH HHS
- Accession Number:
0 (Luminescent Agents)
5TBB02N29K (Firefly Luciferin)
EC 1.13.12.- (Luciferases)
- Publication Date:
Date Created: 20200814 Date Completed: 20210415 Latest Revision: 20240330
- Publication Date:
20240330
- Accession Number:
PMC7867379
- Accession Number:
10.1021/jacs.0c01064
- Accession Number:
32787261
No Comments.